We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abingdon Health Plc | LSE:ABDX | London | Ordinary Share | GB00BLF79J41 | ORD 0.025P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.00 | 10.50 | 11.50 | 11.00 | 11.00 | 11.00 | 44,978 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.05M | -3.45M | -0.0284 | -3.87 | 13.39M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/2/2021 11:50 | >>>hammopj The Mail article states "In December 2019, Abingdon Health was teetering on the brink, with losses of £1.5million. According to its last published accounts, the firm's directors were warning that to survive, it would have to cut costs and seek new investment." They presumably came to this sensationalist conclusion after studying the company accounts (dated December 2019), hence my comment that I found the going concern statement in the accounts, unremarkable. The Daily Mail may well wish to side with Good Law Project againt HMG on the supply of PPE and diagnostics, but it is a total irrelevance to link this to Abingdon Health's prospects as of December 2019 (which pre-dates any discussions on COVID related PPE and diagnostics) | timbo003 | |
08/2/2021 11:21 | It's unremarkable because the contract cancellation was omitted! | hammopj | |
08/2/2021 10:57 | These must be worth buying at this level with news to come. | grosstonnage | |
08/2/2021 08:57 | There are no limits to the corruption surrounding this govts handing of COVID | pomp circumstance | |
08/2/2021 08:07 | The going concern statement in the 2019 accounts looks unremarkable to me, fairly standard stuff for a rapidly growing high tech SME which is going to require further growh capital in order to execute their business plan | timbo003 | |
08/2/2021 07:35 | This appears to be the Daily Mail article referred to in today's RNS | timbo003 | |
02/2/2021 22:40 | We are hosting a webinar with Abingdon Health on the 10th Feb which may be of interest to current investors and potential shareholders: | sharesoc | |
29/1/2021 08:52 | https://www.med-tech | chrisdr2 | |
29/1/2021 08:14 | Can you explain how the government is invested and details of the cpnsortium members? I cannot seem to find info. Thanks | hammopj | |
28/1/2021 15:31 | They're not going after the UK companies. It's GLP v Secretary of State for Health and Social Care. I feel sure the consortium members knew the government had a financial interest in the contract when they got into bed with it. | mr macgregor | |
28/1/2021 15:24 | Good law project would rather go after uk companies rather than go after the government for their purchasing of the innova tests or the 7k per day consultation fees being charged for test and trace Something stinks | jock3636 | |
28/1/2021 15:20 | Well the government awarded a valuable contract to Abingdon's consortium without competitive tender. What seems worse to me is that the government was invested in Abingdon so stood to gain financially from the contract it awarded. That conflict of interest looks like corruption. Since the contract was awarded the values of the companies in the consortium have multiplied. The case is going to court which isn't good for the reputations of the companies involved. This, along with the fact that Abingdon's consortium didn't receive MHRA approval from the UK, at a time when the government desperately wants to promote UK companies and home brew diagnostic tests, presumably won't help the mooted international sales drive. | mr macgregor | |
28/1/2021 11:23 | Why the pannic?? Gov't simply switching to a more competitive purchasing platform as they are under increasing scrutiny. Numbers for H2 stated at c£7.7m v £1.5m H1. On target to obtain accreditation in 27 other countries too. They have other non Covid-19 products too. Investors, dont throw the baby out with the bathwater!! | chrisdr2 | |
27/1/2021 21:45 | Here's a date for your diaries: You will need to register but it is a painless process (and free) 🙂 | timbo003 | |
27/1/2021 21:24 | Note clarification released by the company at 18:13 this evening: | timbo003 | |
27/1/2021 15:57 | The aint going to not place massive orders to placate a few looney liberals. Send em all to Venezuela | hodhasharon | |
27/1/2021 14:03 | Ie. Covering its back - doesn't seem to have affect the sp | janhar | |
27/1/2021 14:02 | Is it possible the government is trying to prove that it wasn't handing out contracts to preferred suppliers rather than going through the correct channels? | janhar | |
27/1/2021 13:55 | No wonder they suddenly rushed to market, there's some odd stuff going on here! | pomp circumstance | |
27/1/2021 13:53 | GET OUT NOW | pomp circumstance | |
26/1/2021 08:49 | hxxps://www.bmj.com/ G. | garth | |
26/1/2021 08:29 | This could be something big when more people catch on to it..Antigen testing very much needed this year if we want normality | allstars001 | |
06/1/2021 09:49 | London’s AIM market had a remarkable 2020, ending the year with its market value at an all-time high, with the AIM index also significantly outperforming other UK main market indices. Investor’s Champion’s monthly update covers all the newcomers from December, including Abingdon Health, and comments on an eventful year for London’s growth market which had a record 24 companies valued at more than £1billion each at the year end. | energeticbacker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions